Cambridge Consultants help Clinigen Group to breathe new life into old drugs

Clinigen is committed to making further drug acquisitions, with a focus on rejuvenating product performance and extending product life by seeking new uses for drugs, extending their geographical sales footprint or reformulating them. Targeted products are niche, hospital-only, mature or end-of-lifecycle drugs.

As part of a six-month project, Cambridge Consultants built a bespoke acquisition database of 4,000 drugs, and screened and ranked them – identifying 150-180 potential targets. A shortlist was then drawn up of 20 hospital-only drugs that would be suitable for more detailed commercial discussions. The process included the analysis of clinical data and interviews with key opinion leaders.

Peter George, chief executive officer of Clinigen, said: “Identifying new drugs is vital to our unique business model and our mission to supply the right drug to the right patient at the right time. Working with Cambridge Consultants allowed us to ensure we developed the most robust and effective process that speeds up decision making to identify drugs to license and bring to market faster with consistent and measured market analysis.”

Clinigen has identified numerous product opportunities from the acquisition database, a number of which are being actively pursued.

Kate Hudson-Farmer, senior consultant at Cambridge Consultants, said: “New critical life-saving treatments are rarely found by serendipity and require strict search and selection processes. Combining these with our market analysis and strategy support, we’ve been able to help Clinigen breathe new life into old drugs.”

Source: http://www.cambridgeconsultants.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Clinigen Group. (2018, July 14). Cambridge Consultants help Clinigen Group to breathe new life into old drugs. News-Medical. Retrieved on May 18, 2024 from https://www.news-medical.net/news/20130724/Cambridge-Consultants-help-Clinigen-Group-to-breathe-new-life-into-old-drugs.aspx.

  • MLA

    Clinigen Group. "Cambridge Consultants help Clinigen Group to breathe new life into old drugs". News-Medical. 18 May 2024. <https://www.news-medical.net/news/20130724/Cambridge-Consultants-help-Clinigen-Group-to-breathe-new-life-into-old-drugs.aspx>.

  • Chicago

    Clinigen Group. "Cambridge Consultants help Clinigen Group to breathe new life into old drugs". News-Medical. https://www.news-medical.net/news/20130724/Cambridge-Consultants-help-Clinigen-Group-to-breathe-new-life-into-old-drugs.aspx. (accessed May 18, 2024).

  • Harvard

    Clinigen Group. 2018. Cambridge Consultants help Clinigen Group to breathe new life into old drugs. News-Medical, viewed 18 May 2024, https://www.news-medical.net/news/20130724/Cambridge-Consultants-help-Clinigen-Group-to-breathe-new-life-into-old-drugs.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
An Introduction to Specialty Pharmaceuticals